Literature DB >> 14679446

The clinical management and outcome of nail salon-acquired Mycobacterium fortuitum skin infection.

Kevin L Winthrop1, Kim Albridge, David South, Peggy Albrecht, Marcy Abrams, Michael C Samuel, Wendy Leonard, Joanna Wagner, Duc J Vugia.   

Abstract

Nontuberculous mycobacterial infections are becoming more common. Recently, Mycobacterium fortuitum and other rapidly growing mycobacteria have been found to cause severe skin and soft-tissue infections in association with nail salon whirlpool footbaths. We recently investigated a large outbreak of M. fortuitum furunculosis among women who received pedicures at a single nail salon. To better define the clinical course of such infections, we collected clinical details from physicians who were treating outbreak patients. We constructed multivariable linear models to evaluate the effect of antibiotic treatment on disease duration. Sixty-one patients were included in the investigation. The mean disease duration was 170 days (range, 41-336 days). Forty-eight persons received antibiotic therapy for a median period of 4 months (range, 1-6 months), and 13 persons were untreated. Isolates were most susceptible to ciprofloxacin and minocycline. Early administration of therapy was associated with shorter duration of disease only in persons with multiple boils (P<.01). One untreated, healthy patient had lymphatic disease dissemination.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14679446     DOI: 10.1086/380459

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  10 in total

1.  Mycobacterium fortuitum infection after a brown bear bite.

Authors:  Ville A Lehtinen; Timo Kaukonen; Irma Ikäheimo; Saara-Mari Mähönen; Markku Koskela; Pekka Ylipalosaari
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

Review 2.  [Skin and soft tissue infections due to non-tuberculous mycobacteria: etiology, epidemiology, pathogenesis, differential diagnostic aspects and therapeutic recommendations].

Authors:  Pietro Nenoff; Georgi Tchernev; Uwe Paasch; Werner Handrick
Journal:  Wien Med Wochenschr       Date:  2011-09

3.  Mycobacterium fortuitum infection of the scalp after a skin graft.

Authors:  Blaine D Smith; Ioannis N Liras; Ignacio A De Cicco; Gabriel Marcelo Aisenberg
Journal:  BMJ Case Rep       Date:  2016-10-19

Review 4.  Clinical and laboratory aspects of the diagnosis and management of cutaneous and subcutaneous infections caused by rapidly growing mycobacteria.

Authors:  R J Kothavade; R S Dhurat; S N Mishra; U R Kothavade
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-09       Impact factor: 3.267

5.  Mycobacteria in nail salon whirlpool footbaths, California.

Authors:  Duc J Vugia; Yvonne Jang; Candi Zizek; Janet Ely; Kevin L Winthrop; Edward Desmond
Journal:  Emerg Infect Dis       Date:  2005-04       Impact factor: 6.883

Review 6.  Global Environmental Nontuberculous Mycobacteria and Their Contemporaneous Man-Made and Natural Niches.

Authors:  Jennifer R Honda; Ravleen Virdi; Edward D Chan
Journal:  Front Microbiol       Date:  2018-08-30       Impact factor: 5.640

7.  Transcriptional analysis of Mycobacterium fortuitum cultures upon hydrogen peroxide treatment using the novel standard rrnA-P1.

Authors:  María Carmen Núñez; María Carmen Menéndez; María José Rebollo; María J García
Journal:  BMC Microbiol       Date:  2008-06-19       Impact factor: 3.605

8.  Mycobacterium fortuitum skin infection as a complication of anabolic steroids: a rare case report.

Authors:  R Pai; U Parampalli; G Hettiarachchi; I Ahmed
Journal:  Ann R Coll Surg Engl       Date:  2013-01       Impact factor: 1.951

9.  Cutaneous Mycobacterium fortuitum Infection: Successfully Treated with Amikacin and Ofloxacin Combination.

Authors:  Sunil Sethi; Shilpa Arora; Vikas Gupta; Shiv Kumar
Journal:  Indian J Dermatol       Date:  2014-07       Impact factor: 1.494

Review 10.  Treatment of Extrapulmonary Nontuberculous Mycobacterial Diseases.

Authors:  Yu Mi Wi
Journal:  Infect Chemother       Date:  2019-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.